What does Imroder do?
IMRODER specializes in the development and production of innovative medical devices that enhance patient care. The company focuses on creating solutions that improve the efficiency of healthcare processes and outcomes. With a commitment to quality and sustainability, IMRODER aims to lead advancements in the medical technology sector.
- Sectors
- Real estate agencies
- Activities
- Signals
-
Poor liquidityPoor liquidity 0.95
The current ratio is below 1: may be insufficient to cover short-term debt.
ProfitableProfitable € 501KThe company reported a positive net result in the latest financial year.
Strong equityStrong equity € 21.63MStrong equity provides a buffer against setbacks.
Low riskLow risk 53.0%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 2.00MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 2.74MPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 6.22MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 15.0%Social debts stay manageable relative to personnel costs.
- Investments
- Imroder Construct 99,9%, Kotcompany 33,33%, Holberg 12,22%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
6.22M
|
€
2.52M
|
|
|
|
|
€
2.74M
|
€
2.61M
|
€
5.41M
|
€
4.31M
|
|
|
€
501K
|
€
-224K
|
€
2.30M
|
€
666K
|
|
|
€
21.63M
|
€
21.12M
|
€
21.35M
|
€
19.05M
|
|
|
53.02%
|
44.85%
|
42.44%
|
36.77%
|
|
|
€
17.71M
|
€
24.41M
|
€
27.34M
|
€
31.02M
|
|
|
€
1.26M
|
€
3.10M
|
€
3.68M
|
€
2.50M
|
|
|
7.60
|
7.60
|
7.40
|
8.00
|
Publications 6
All publications- Doel 11/01/2024
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Doel - Ontslagen - Benoemingen 08/07/2020
- Me. - Jaarrekening 31.12.2016, Ggk 30.05.2017, Ngl 19.06.2017 17189-0503-014 23/06/2017
- Ontslagen - Benoemingen 15/06/2017
- Diversen 18/02/2016
Frequently asked questions
Answers to the most common questions about Imroder, based on official government data and the filed annual accounts.
What is the VAT number of Imroder?
The VAT number of Imroder is BE0634.911.817.
How many employees work at Imroder?
In 2025, Imroder employed 7.60 full-time equivalents (FTE).
When was Imroder established?
Imroder was founded in 31-07-2015.
What is the official address of Imroder?
The official address of Imroder is Kortrijksesteenweg 154 Sint-Martens-Latem 9830.
What is the legal form of Imroder?
The juridical form of Imroder is Public limited company (NV/SA).
What is the annual revenue of Imroder?
The revenue of Imroder for the 2025 financial year was €6,220,506.
What does Imroder do?
IMRODER specializes in the development and production of innovative medical devices that enhance patient care. The company focuses on creating solutions that improve the efficiency of healthcare processes and outcomes. With a commitment to quality and sustainability, IMRODER aims to lead advancements in the medical technology sector.
Is Imroder a reliable company?
Imroder is a registered Rechtspersoon with company number 0634.911.817 and can be verified through the official CBE database.
What is the credit limit of Imroder?
The estimated credit limit of Imroder is €4,551,141.
Is Imroder still active?
Imroder currently has the status "Normal situation" and is active.